These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Hydrogel Based Allergen-Coated Gold Nanoparticles for Topical Administration: A Possible Epicutaneous Immunotherapy in Pollen-Sensitized Mice? Pordel S; Rezaee M; Moghadam M; Sankian M Immunol Invest; 2024 Apr; 53(3):523-539. PubMed ID: 38166585 [TBL] [Abstract][Full Text] [Related]
3. Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. Su X; Kim BS; Kim SR; Hammond PT; Irvine DJ ACS Nano; 2009 Nov; 3(11):3719-29. PubMed ID: 19824655 [TBL] [Abstract][Full Text] [Related]
5. A crucial role for Jagunal homolog 1 in humoral immunity and antibody glycosylation in mice and humans. Hagelkruys A; Wirnsberger G; Stadlmann J; Wöhner M; Horrer M; Vilagos B; Jonsson G; Kogler M; Tortola L; Novatchkova M; Bönelt P; Hoffmann D; Koglgruber R; Steffen U; Schett G; Busslinger M; Bergthaler A; Klein C; Penninger JM J Exp Med; 2021 Jan; 218(1):. PubMed ID: 32930709 [TBL] [Abstract][Full Text] [Related]
6. Macropinocytosis Is the Principal Uptake Mechanism of Antigen-Presenting Cells for Allergen-Specific Virus-like Nanoparticles. Kraus A; Kratzer B; Sehgal ANA; Trapin D; Khan M; Boucheron N; Pickl WF Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066435 [TBL] [Abstract][Full Text] [Related]
7. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin. Shah SA; Oakes RS; Jewell CM Adv Drug Deliv Rev; 2024 Jun; 209():115315. PubMed ID: 38670230 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in epicutaneous immunotherapy and potential applications in food allergy. Hervé PL; Dioszeghy V; Matthews K; Bee KJ; Campbell DE; Sampson HA Front Allergy; 2023; 4():1290003. PubMed ID: 37965375 [TBL] [Abstract][Full Text] [Related]
9. New routes of allergen immunotherapy. Aricigil M; Muluk NB; Sakarya EU; Sakalar EG; Senturk M; Reisacher WR; Cingi C Am J Rhinol Allergy; 2016 Nov; 30(6):193-197. PubMed ID: 28124639 [TBL] [Abstract][Full Text] [Related]
10. Langerhans cells as targets for immunotherapy against skin cancer. Stoitzner P; Sparber F; Tripp CH Immunol Cell Biol; 2010; 88(4):431-7. PubMed ID: 20351746 [TBL] [Abstract][Full Text] [Related]
11. Pre-Existing Humoral Immunity Enhances Epicutaneously-Administered Allergen Capture by Skin DC and Their Migration to Local Lymph Nodes. Hervé PL; Plaquet C; Assoun N; Oreal N; Gaulme L; Perrin A; Bouzereau A; Dhelft V; Labernardière JL; Mondoulet L; Sampson HA Front Immunol; 2021; 12():609029. PubMed ID: 33868229 [TBL] [Abstract][Full Text] [Related]
12. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice. Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H Front Immunol; 2018; 9():1951. PubMed ID: 30233572 [TBL] [Abstract][Full Text] [Related]
13. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. Dioszeghy V; Mondoulet L; Dhelft V; Ligouis M; Puteaux E; Benhamou PH; Dupont C J Immunol; 2011 May; 186(10):5629-37. PubMed ID: 21490160 [TBL] [Abstract][Full Text] [Related]
14. Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy. Yasuda T; Ura T; Taniguchi M; Yoshida H PLoS One; 2016; 11(12):e0167952. PubMed ID: 27973543 [TBL] [Abstract][Full Text] [Related]